Comparison of microsphere-equivalent blood flow (15O-water PET) and relative perfusion (99mTc-tetrofosmin SPECT) in myocardium showing metabolism-perfusion mismatch.

UNLABELLED Myocardial perfusion imaging with (99m)Tc-tetrofosmin is based on the assumption of a linear correlation between myocardial blood flow (MBF) and tracer uptake. However, it is known that (99m)Tc-tetrofosmin uptake is directly related to energy-dependent transport processes, such as Na(+)/H(+) ion channel activity, as well as cellular and mitochondrial membrane potentials. Therefore, cellular alterations that affect these energy-dependent transport processes ought to influence (99m)Tc-tetrofosmin uptake independently of blood flow. Because metabolism ((18)F-FDG)-perfusion ((99m)Tc-tetrofosmin) mismatch myocardium (MPMM) reflects impaired but viable myocardium showing cellular alterations, MPMM was chosen to quantify the blood flow-independent effect of cellular alterations on (99m)Tc-tetrofosmin uptake. Therefore, we compared microsphere-equivalent MBF (MBF_micr; (15)O-water PET) and (99m)Tc-tetrofosmin uptake in MPMM and in "normal" myocardium. METHODS Forty-two patients with severe coronary artery disease, referred for myocardial viability diagnostics, were examined using (18)F-FDG PET and (99m)Tc-tetrofosmin perfusion SPECT. Relative (18)F-FDG and (99m)Tc-tetrofosmin uptake values were calculated using 18 segments per patient. Normal myocardium and MPMM myocardium were classified using a previously validated (99m)Tc-tetrofosmin SPECT/(18)F-FDG PET score. In addition, (15)O-water PET was performed to assess kinetic-modeled MBF (MBF_kin), the water-perfusable tissue fraction (PTF), and the resulting MBF_micr (MBF_kin x PTF), which is comparable to tracer uptake values. (99m)Tc-tetrofosmin uptake and MBF_micr values were calculated for all normal and MPMM segments and averaged within their respective classifications. RESULTS Mean relative (99m)Tc-tetrofosmin uptake was 86% +/- 1% in normal myocardium and 56% +/- 1% in MPMM, showing a significant difference (P < 0.001), as was expected from the classification. Contrary to these findings, mean MBF_micr in MPMM myocardium was 0.60 +/- 0.03 mL x min(-1) x mL(-1), which did not significantly differ from normal myocardium (0.64 +/- 0.01 mL x min(-1) x mL(-1)). All values are given as mean +/- SEM. CONCLUSION Differences between reduced (99m)Tc-tetrofosmin uptake and the unchanged MBF_micr in MPMM myocardium suggest that the pathophysiologic basis of MPMM is not a blood flow reduction but cellular alterations that affect uptake and retention of (99m)Tc-tetrofosmin independently of blood flow. Therefore, it seems that perfusion deficits in MPMM myocardium are greatly overestimated by (99m)Tc-tetrofosmin and that it tends to give false-positive findings.

[1]  R. Pickett,et al.  Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[2]  B J Messmer,et al.  Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography. , 1996, Journal of the American College of Cardiology.

[3]  A. Lammertsma,et al.  Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  G. Schulz,et al.  Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. , 1998, Journal of the American College of Cardiology.

[5]  G. Beller,et al.  99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  J. Vanoverschelde,et al.  Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant , 1998, Molecular and Cellular Biochemistry.

[7]  Shengshou Hu,et al.  Clinical Outcome of Patients with Previous Myocardial Infarction and Left Ventricular Dysfunction Assessed with Myocardial , 2001 .

[8]  T. Araki,et al.  Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R. Okada,et al.  Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. , 1988, Circulation.

[10]  U. Ruotsalainen,et al.  Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  A Bol,et al.  Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation. , 1996, Circulation.

[12]  A. Luxen,et al.  Direct Comparison of [13N]Ammonia and [150]Water Estimates of Perfusion With Quantification of Regional Myocardial Blood Flow by Microspheres , 1993, Circulation.

[13]  J. Maublant,et al.  Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[14]  R. Walsh,et al.  Flow versus uptake comparisons of thallium-201 with technetium-99m perfusion tracers in a canine model of myocardial ischemia. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  L. Mansi,et al.  Effect of trimetazidine on 99Tcm-tetrofosmin uptake in patients with coronary artery disease , 2000, Nuclear medicine communications.

[16]  Shengshou Hu,et al.  Clinical Outcome of Patients with Previous Myocardial Infarction and Left Ventricular Dysfunction Assessed with Myocardial 99mTc-MIBI SPECT and 18F-FDG PET , 2001 .

[17]  B J Messmer,et al.  Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  Yasuo Kuwabara,et al.  Quantitative assessment of regional myocardial blood flow using oxygen-15-labelled water and positron emission tomography: a multicentre evaluation in Japan , 2000, European Journal of Nuclear Medicine.

[19]  A. Sinusas,et al.  Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  G. Schulz,et al.  [A method for combined scatter and attenuation correction without transmission measurement for myocardial SPECT with 99m-Tc binding]. , 1997, Nuklearmedizin. Nuclear medicine.

[21]  T. Araki,et al.  Ion transport systems in the uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201Tl in a tumour cell line. , 1997, Nuclear medicine communications.

[22]  F. Fazio,et al.  Specificity and sensitivity of exercise-induced ST segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography. , 1995, Journal of the American College of Cardiology.

[23]  Keishi Kitamura,et al.  Histochemical Correlates of 15O-Water–Perfusable Tissue Fraction in Experimental Canine Studies of Old Myocardial Infarction , 2000 .

[24]  H. Iida,et al.  Myocardial tissue fraction--correction for partial volume effects and measure of tissue viability. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  F. Sheehan,et al.  Myocyte degeneration and cell death in hibernating human myocardium. , 1996, Journal of the American College of Cardiology.

[26]  Effects of acute ischemia and reperfusion on the myocardial kinetics of technetium 99m-labeled tetrofosmin and thallium-201 , 1997, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[27]  F Shishido,et al.  Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. , 1988, Circulation.